Signal mining and risk analysis of Alprazolam adverse events based on the FAERS database

Abstract This study aims to evaluate the safety of Alprazolam by analyzing the FAERS database, provide data analysis for monitoring adverse drug reactions. This research encompasses adverse event (AE) reports related to Alprazolam from the first quarter of 2004 to the second quarter of 2023. Four si...

Full description

Bibliographic Details
Main Authors: Feng Huang, Xiao San, Qingqian Liu, Haohao Zhu, Wenrong Xu
Format: Article
Language:English
Published: Nature Portfolio 2024-03-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-57909-y
_version_ 1797233627800535040
author Feng Huang
Xiao San
Qingqian Liu
Haohao Zhu
Wenrong Xu
author_facet Feng Huang
Xiao San
Qingqian Liu
Haohao Zhu
Wenrong Xu
author_sort Feng Huang
collection DOAJ
description Abstract This study aims to evaluate the safety of Alprazolam by analyzing the FAERS database, provide data analysis for monitoring adverse drug reactions. This research encompasses adverse event (AE) reports related to Alprazolam from the first quarter of 2004 to the second quarter of 2023. Four signal mining and analysis methods were utilized, including Reporting Odds Ratio (ROR), Proportional Reporting Ratio (PRR), Bayesian Confidence Propagation Neural Network (BCPNN), and Empirical Bayesian Geometric Mean (EBGM). Further exploration was conducted regarding patient characteristics and types of AEs. A total of 23,575 AE reports in which Alprazolam was the primary suspect drug were collected, identifying 347 Preferred Term (PT) signals and 27 System Organ Classes (SOCs). The number of AE reports increased annually, especially in 2015, 2018, 2019, and 2020. The main affected groups were females and the age range of 18 to 45. Psychiatric disorders, Nervous system disorders, and Gastrointestinal disorders were the most common the organ system in which the AEs occurred. There is a certain risk of drug abuse and suicide with Alprazolam. Most notably, several AEs not recorded in the Alprazolam leaflet appeared among the top 30 PTs in signal strength, including but not limited to Benzodiazepine drug level abnormal, Acquired amegakaryocytic thrombocytopenia, Cutaneous T-cell dyscrasia, and Coronary No-reflow Phenomenon. For the first time, AEs related to the cardiovascular system and platelet function were unveiled. The severe AE reports that resulted in "hospitalization" and "death" accounted for 30.96% and 21.86%. This study highlights the risks of suicide and misuse of Alprazolam. Other potential severe or fatal AEs, such as those related to the cardiovascular system, platelet function, and others, require further research to determine their precise mechanisms and risk factors.
first_indexed 2024-04-24T16:19:11Z
format Article
id doaj.art-e2f78a8b10e54e3e811cd17a9cf48454
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-24T16:19:11Z
publishDate 2024-03-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-e2f78a8b10e54e3e811cd17a9cf484542024-03-31T11:18:43ZengNature PortfolioScientific Reports2045-23222024-03-011411910.1038/s41598-024-57909-ySignal mining and risk analysis of Alprazolam adverse events based on the FAERS databaseFeng Huang0Xiao San1Qingqian Liu2Haohao Zhu3Wenrong Xu4Department of Clinical Laboratory, Kunshan Maternity and Children’s Health Care HospitalJiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu UniversityDepartment of Clinical Laboratory, The First People’s Hospital of Kunshan Affiliated With Jiangsu UniversityMental Health Center of Jiangnan University, Wuxi Central Rehabilitation HospitalJiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu UniversityAbstract This study aims to evaluate the safety of Alprazolam by analyzing the FAERS database, provide data analysis for monitoring adverse drug reactions. This research encompasses adverse event (AE) reports related to Alprazolam from the first quarter of 2004 to the second quarter of 2023. Four signal mining and analysis methods were utilized, including Reporting Odds Ratio (ROR), Proportional Reporting Ratio (PRR), Bayesian Confidence Propagation Neural Network (BCPNN), and Empirical Bayesian Geometric Mean (EBGM). Further exploration was conducted regarding patient characteristics and types of AEs. A total of 23,575 AE reports in which Alprazolam was the primary suspect drug were collected, identifying 347 Preferred Term (PT) signals and 27 System Organ Classes (SOCs). The number of AE reports increased annually, especially in 2015, 2018, 2019, and 2020. The main affected groups were females and the age range of 18 to 45. Psychiatric disorders, Nervous system disorders, and Gastrointestinal disorders were the most common the organ system in which the AEs occurred. There is a certain risk of drug abuse and suicide with Alprazolam. Most notably, several AEs not recorded in the Alprazolam leaflet appeared among the top 30 PTs in signal strength, including but not limited to Benzodiazepine drug level abnormal, Acquired amegakaryocytic thrombocytopenia, Cutaneous T-cell dyscrasia, and Coronary No-reflow Phenomenon. For the first time, AEs related to the cardiovascular system and platelet function were unveiled. The severe AE reports that resulted in "hospitalization" and "death" accounted for 30.96% and 21.86%. This study highlights the risks of suicide and misuse of Alprazolam. Other potential severe or fatal AEs, such as those related to the cardiovascular system, platelet function, and others, require further research to determine their precise mechanisms and risk factors.https://doi.org/10.1038/s41598-024-57909-yAlprazolamFAERSReal-world data analysisAdverse eventsAdverse drug reaction
spellingShingle Feng Huang
Xiao San
Qingqian Liu
Haohao Zhu
Wenrong Xu
Signal mining and risk analysis of Alprazolam adverse events based on the FAERS database
Scientific Reports
Alprazolam
FAERS
Real-world data analysis
Adverse events
Adverse drug reaction
title Signal mining and risk analysis of Alprazolam adverse events based on the FAERS database
title_full Signal mining and risk analysis of Alprazolam adverse events based on the FAERS database
title_fullStr Signal mining and risk analysis of Alprazolam adverse events based on the FAERS database
title_full_unstemmed Signal mining and risk analysis of Alprazolam adverse events based on the FAERS database
title_short Signal mining and risk analysis of Alprazolam adverse events based on the FAERS database
title_sort signal mining and risk analysis of alprazolam adverse events based on the faers database
topic Alprazolam
FAERS
Real-world data analysis
Adverse events
Adverse drug reaction
url https://doi.org/10.1038/s41598-024-57909-y
work_keys_str_mv AT fenghuang signalminingandriskanalysisofalprazolamadverseeventsbasedonthefaersdatabase
AT xiaosan signalminingandriskanalysisofalprazolamadverseeventsbasedonthefaersdatabase
AT qingqianliu signalminingandriskanalysisofalprazolamadverseeventsbasedonthefaersdatabase
AT haohaozhu signalminingandriskanalysisofalprazolamadverseeventsbasedonthefaersdatabase
AT wenrongxu signalminingandriskanalysisofalprazolamadverseeventsbasedonthefaersdatabase